↓ Skip to main content

Single dose oral celecoxib for acute postoperative pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
13 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single dose oral celecoxib for acute postoperative pain in adults
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd004233.pub4
Pubmed ID
Authors

Sheena Derry, R Andrew Moore

Abstract

This is an update of a review first published in The Cochrane Library in Issue 4, 2008, and updated in Issue 3, 2012. Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor usually prescribed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis. Celecoxib is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs). Its effectiveness in acute pain was demonstrated in the earlier reviews.

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Brazil 1 1%
Italy 1 1%
Canada 1 1%
Malaysia 1 1%
Unknown 86 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 20%
Other 14 15%
Student > Bachelor 12 13%
Researcher 9 10%
Student > Postgraduate 8 9%
Other 20 22%
Unknown 11 12%
Readers by discipline Count As %
Medicine and Dentistry 54 59%
Nursing and Health Professions 7 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 4 4%
Social Sciences 2 2%
Other 7 8%
Unknown 13 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2018.
All research outputs
#1,403,914
of 13,218,487 outputs
Outputs from Cochrane database of systematic reviews
#4,001
of 10,527 outputs
Outputs of similar age
#21,973
of 181,853 outputs
Outputs of similar age from Cochrane database of systematic reviews
#41
of 102 outputs
Altmetric has tracked 13,218,487 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.7. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.